COVID-19: Changing the Face of Cancer Care

A checkpoint inhibitor combination and an antibody-drug conjugate may offer new treatment options.

But persistent racial disparities mean Black women diagnosed with the aggressive disease have a shorter life expectancy.

Long-term COVID-19 raises several policy issues. For people affected, none is more urgent than the threat of losing their health insurance.

Diagnosed 10 months ago, the 32-year-old political strategist is receiving targeted therapy.

Nationwide, surveys have found increasing rates of depression, anxiety and suicidal thoughts during the pandemic.

The best-performing combo, firsocostat and cilofexor, showed benefits despite missing the main study endpoint.

These three respiratory illnesses share many of the same symptoms.

He didn’t provide many details but said he would be undergoing treatment.

The conservative radio talk show titan told listeners that he hopes to continue to stay on the air as much as he can.